{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:29:12Z","timestamp":1745411352257},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10006-020-00931-x","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T10:06:10Z","timestamp":1610013970000},"page":"421-425","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bosutinib-induced osteonecrosis of the jaw in a patient with chronic myeloid leukemia: a case report"],"prefix":"10.1007","volume":"25","author":[{"given":"Yoshinari","family":"Myoken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Imanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Toratani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"931_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"931_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00520-018-4501-x","volume":"27","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, Elad S, Campisi G, Tsoukalas N, Bektas-Kayhan K, MASCC Bone Study Group et al (2019) Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. Support Care Cancer 27:383\u2013394","journal-title":"Support Care Cancer"},{"key":"931_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.oooo.2017.10.010","volume":"125","author":"H Abel Mahedi Mohamed","year":"2018","unstructured":"Abel Mahedi Mohamed H, Nielsen CEN, Schiodt M (2018) Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort. Oral Surg Oral Med Oral Pathol Oral Radiol 125:157\u2013163","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"931_CR4","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1016\/j.oooo.2018.05.008","volume":"126","author":"AM Won","year":"2018","unstructured":"Won AM, Boddu P, Otun AO, Aponte-Wesson R, Chambers M (2018) Chronic myelogenous leukemia presenting with osteonecrosis of the jaw as a rare but debilitating toxicity of dasatinib: a case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol 126:e208\u2013e211","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"931_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5125\/jkaoms.2017.43.2.120","volume":"43","author":"M Vivano","year":"2017","unstructured":"Vivano M, Rossi M, Cocca S (2017) A rare case of osteonecrosis of the jaw related to imatinib. J Korean Assoc Oral Maxillofac Surg 43:120\u2013124","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"931_CR6","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.ijom.2019.07.010","volume":"48","author":"R Mauceri","year":"2019","unstructured":"Mauceri R, Panzarella V, Morreale I, Campisi G (2019) Medication-related osteonecrosis of the jaw in a cancer patient receiving lenvatinib. Int J Oral Maxillofac Surg 48:1530\u20131532","journal-title":"Int J Oral Maxillofac Surg"},{"key":"931_CR7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.bjoms.2019.05.017","volume":"57","author":"S Akkach","year":"2019","unstructured":"Akkach S, Shukla L, Morgan D (2019) Everolimus-induced osteonecrosis of the jaw in the absence of bisphosphonates: a case report. Br J Oral Maxillofac Surg 57:688\u2013690","journal-title":"Br J Oral Maxillofac Surg"},{"key":"931_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13045-018-0685-2","volume":"11","author":"JE Cortes","year":"2018","unstructured":"Cortes JE, Apperley JF, DeAngelo DJ, Deininger MW, Kota VK, Rousselot P, Gambacorti-Passerini C (2018) Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review. J Hematol Oncol 11:143","journal-title":"J Hematol Oncol"},{"key":"931_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1200\/JCO.2017.74.7162","volume":"36","author":"JE Cortes","year":"2018","unstructured":"Cortes JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, le Coutre P, Garcia-Gutierrez V, Reilly L, Jeynes-Ellis A, Leip E, Bardy-Bouxin N, Hochhaus A, Br\u00fcmmendorf TH (2018) Bosutinib versus Imatinib for newly diagnosed chronic myeloid leukemia: results from the randomized BFORE trial. J Clin Oncol 36:231\u2013237","journal-title":"J Clin Oncol"},{"key":"931_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.joms.2017.09.021","volume":"76","author":"J Lemound","year":"2018","unstructured":"Lemound J, Muecke T, Zeller AN, Lichtenstein J, Eckardt A, Gellrich NC (2018) Nasolabial flap improves healing in medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg 76:877\u2013885","journal-title":"J Oral Maxillofac Surg"},{"key":"931_CR11","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.18632\/oncotarget.13643","volume":"8","author":"S Bieerkehazhi","year":"2017","unstructured":"Bieerkehazhi S, Chen Z, Zhao Y, Yu Y, Zhang H, Vasudevan SA, Woodfield SE, Tao L, Yi JS, Muscal JA, Pang JC, Guan S, Zhang H, Nuchtern JG, Li H, Li H, Yang J (2017) Novel Src\/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src\/Abl signaling. Oncotarget 8:1469\u20131480","journal-title":"Oncotarget"},{"key":"931_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/10428194.2018.1466294","volume":"60","author":"A Gover-Proaktor","year":"2019","unstructured":"Gover-Proaktor A, Granot G, Pasmanik-Chor M, Pasvolsky O, Shapira S, Raz O, Raanani P, Leader A (2019) Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells. Leuk Lymphoma 60:189\u2013199","journal-title":"Leuk Lymphoma"},{"key":"931_CR13","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/jbmr.3191","volume":"32","author":"S Hayashida","year":"2017","unstructured":"Hayashida S, Soutome S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Umeda M (2017) Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis. J Bone Miner Res 32:2022\u20132029","journal-title":"J Bone Miner Res"},{"key":"931_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jcms.2015.12.017","volume":"44","author":"T M\u00fccke","year":"2016","unstructured":"M\u00fccke T, Koerdt S, Jung M, Mitchell DA, Wolff KD, Kesting MR, Loeffelbein DJ (2016) The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws. J Craniomaxillofac Surg 44:369\u2013373","journal-title":"J Craniomaxillofac Surg"},{"key":"931_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.joms.2019.08.028","volume":"78","author":"Y Myoken","year":"2020","unstructured":"Myoken Y, Fujita Y, Okamoto T (2020) Modified submental island flap for the surgical treatment of 4 patients with stage 3 medication-related osteonecrosis of the mandible. J Oral Maxillofac Surg 78:29\u201334","journal-title":"J Oral Maxillofac Surg"},{"key":"931_CR16","doi-asserted-by":"publisher","first-page":"104874","DOI":"10.1016\/j.oraloncology.2020.104874","volume":"27","author":"Y Myoken","year":"2020","unstructured":"Myoken Y, Fujita Y, Kawamoto K, Toratani S (2020) Osteonecrosis of the jaw in a metastatic lung cancer patient with bone metastases undergoing pembrolizumab+denosumab combination therapy: case report and literature review. Oral Oncol 27:104874. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104874","journal-title":"Oral Oncol"},{"key":"931_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/odi.13556","volume":"2020","author":"O Ristow","year":"2020","unstructured":"Ristow O, R\u00fcckschlo\u00df T, Moratin J, M\u00fcller M, K\u00fchle R, Dominik H, Pilz M, Shavlokhova V, Otto S, Hoffmann J et al (2020) Wound closure and alveoplasty after preventive tooth extractions in patients with antiresorptive intake-a randomized pilot trial. Oral Dis 2020:17. https:\/\/doi.org\/10.1111\/odi.13556","journal-title":"Oral Dis"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-020-00931-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-020-00931-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-020-00931-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T04:07:21Z","timestamp":1628482041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-020-00931-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["931"],"URL":"https:\/\/doi.org\/10.1007\/s10006-020-00931-x","relation":{},"ISSN":["1865-1550","1865-1569"],"issn-type":[{"value":"1865-1550","type":"print"},{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This report was approved by the Institutional Review Board of Hiroshima Red Cross & Atomic-bomb Survivors Hospital (approval no. H 30-645).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written consent was obtained for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}